Peter Attia· MD
we're doing a study like this in in Singapore on humans, six-month intervention with rapamy. Um and we're looking as many different parameters of a we're not doing disease. In fact, we're not taking people with disease. We're taking people that are 40 to 60. They may have a precondition for a disease, but they don't have anything that would be defined as a disease. Okay. Um so it could be, you know, high glucose, but not diabet, you know, and and so the um and then we're looking at changes in a wide range of different biomarkers, clocks which So tell me a little bit more about the study? So how many subjects? Um we're doing these I don't remember the exact numbers. It's somewhere around 150 to 200. So it's not huge. And how you're dosing it? Um intermittently. Um once a week, how much? Yeah. Uh I think it's 5 milligrams is what's in the protocol.